Cassava Sciences, Inc. (SAVA)
NASDAQ: SAVA · Real-Time Price · USD
2.120
+0.090 (4.43%)
At close: Mar 9, 2026, 4:00 PM EDT
2.060
-0.060 (-2.83%)
After-hours: Mar 9, 2026, 7:47 PM EDT
Cassava Sciences Market Cap
Cassava Sciences has a market cap or net worth of $102.41 million as of March 9, 2026. Its market cap has decreased by -21.16% in one year.
Market Cap
102.41M
Enterprise Value
-8.01M
1-Year Change
-21.16%
Ranking
Category
Stock Price
$2.12
Market Cap Chart
Since July 14, 2000, Cassava Sciences's market cap has decreased from $212.59M to $102.41M, a decrease of -51.83%. That is a compound annual growth rate of -2.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 98.07M | 2.53% |
| Dec 31, 2025 | 95.65M | -15.76% |
| Dec 31, 2024 | 113.54M | -88.04% |
| Dec 29, 2023 | 949.34M | -22.98% |
| Dec 30, 2022 | 1.23B | -29.52% |
| Dec 31, 2021 | 1.75B | 633.58% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Korro Bio | 105.29M |
| Fortress Biotech | 103.67M |
| Turn Therapeutics | 103.06M |
| Agenus | 100.66M |
| Seer, Inc. | 100.43M |
| Biomea Fusion | 98.28M |
| Dogwood Therapeutics | 96.22M |
| Anixa Biosciences | 95.13M |